Radiologists should suggest what kind of imaging is best suited for a pregnant patient presenting with an acute condition. The type of imaging study is planned in close consultation with the clinical team. Ultrasonography (US) should always be the initial modality for evaluation of a pregnant patient, especially in abdominal emergencies. In other conditions like suspected pulmonary embolism or neurological emergencies ultrasound doesn't help, so using other diagnostic modalities like CT and MRI will be necessary. A recurring debate in many radiology practices is the concern of radiologists about performing an examination that exposes a fetus to radiation. This literature review aims to identify an optimal imaging strategy for the accurate detection of different acute medical non-traumatic emergencies in pregnant patients.
Introduction
Radiologists should suggest what kind of imaging is best suited for a pregnant patient presenting with an acute condition. The type of imaging study is planned in close consultation with the clinical team. Ultrasonography (US) should always be the initial modality for evaluation of a pregnant patient, especially in abdominal emergencies. In other conditions like suspected pulmonary embolism or neurological emergencies ultrasound doesn't help, so using other diagnostic modalities like CT and MRI will be necessary. A recurring debate in many radiology practices is the concern of radiologists about performing an examination that exposes a fetus to radiation. A recent literature review demonstrated that in general, there is a lower than expected awareness of radiation risks associated with imaging pregnant women both among radiologists and among clinicians.
Radiation Effects
The effects of radiation exposure have been studied extensively and the risks of radiation can be categorized as stochastic and nonstochastic effects.
Stochastic Effects
Stochastic effects are the result of cellular damage, likely at the DNA level, causing cancer or other germ cell mutation. Stochastic effects have no threshold value and are theorized to occur with exposure to any amount of ionizing radiation. The severity of radiation-induced stochastic effects is independent of the radiation dose. Historically, the radiation dose estimated for stochastic effects, as based on probability, was established at 50 mGy (5 rad) 1-4 American College of Radiology (ACR) produced practice guidelines for imaging pregnant patients and provided an approximation of fetal risk at various gestational ages with differing radiation exposure ( As shown in Table 1 , the ACR suggested that theoretical risks are not likely at doses less than 100 mGy (10 rad). 7
Nonstochastic Effects
Nonstochastic effects (threshold effects) are caused by exposure to radiation at high doses. These effects are predictable and involve multicellular injury, which can include chromosome aberrations. Threshold effects follow a linear progression, with risk increasing with increasing dose 2,4 ).
Historically, the threshold dose has been estimated to be 150 mGy (15 rad) (8). At this dose, it is recommended for the pregnancy to be terminated. 
Imaging Pregnant Patients with Suspected Pulmonary Embolism
A diagnosis of pulmonary embolism in pregnancy has important implications, including the need for prolonged anticoagulation therapy, delivery planning, and possible prophylaxis during future pregnancies, as well as concern about future oral contraceptive use and estrogen therapy. [10] [11] [12] [13] 16 The clinical pathway for evaluating pregnant patients with suspected pulmonary embolism has been a topic of debate. [13] [14] [15] In the absence of standard guidelines, there is aneed to familiarize radiologists with the relative advances and limitations of various tests used. 
Recommendations that comes on based on the algorithm: 17
Recommendation 1.
In pregnant women with suspected PE, we suggest that D-dimer not be used to exclude PE (weak recommendation, very-low-quality evidence).
Recommendation 2.
In pregnant women with suspected PE and signs and symptoms of deep venous thrombosis (DVT), is suggested performing bilateral venous compression ultrasound (CUS) of lower extremities, followed by anticoagulation treatment if positive and by further testing if negative (weak recommendation, very-low-quality evidence). Recommendation 3. In pregnant women with suspected PE and no signs and symptoms of DVT, is suggested performing studies of the pulmonary vasculature rather than CUS of the lower extremities (weak recommendation, very-low-quality evidence).
Recommendation 4.
In pregnant women with suspected PE, is recommended a CXR as the first radiation-associated procedure in the imaging work-up (strong recommendation, low-quality evidence). Recommendation 5. In pregnant women with suspected PE and a normal CXR, is recommended lung scintigraphy as the next imaging test rather than CTPA (strong recommendation, low-quality evidence). Recommendation 6. In pregnant women with suspected PE and a nondiagnostic V/ Q scan, is suggested further diagnostic test-ing rather than clinical management alone (weak recommendation, low-quality evidence). In patients with a nondiagnostic V/ Q scan in whom a decision is made to further investigate, is recommended CTPA rather than DSA (strong recommendation, verylow-quality evidence). Recommendation 7.
In pregnant women with suspected PE and an abnormal CXR, is suggested CTPA as the next imaging test rather than lung scintigraphy (weak recommendation, very-low-quality evidence) Based on recommendations above, none of them was statistically superior to others. In making recommendations and considering their strength, the panel placed a higher value on minimizing radiation dose and a lower value on test rapidity, test potential to provide alternate diagnosis, and cost. What are the risks to mother and fetus when diagnostic studies requiring radiation are performed? Table 4 shows measured radiation doses to fetus and mother associated with diagnostic tests for suspected PE in pregnancy. 17 It is important to note that there is an estimated 30-630-fold greater breast dose with CT pulmonary angiography (10-70 mGy) than with low-dose perfusion scintigraphy, with breast dose values well above the traditional 3 mGy used in screening mammography and equivalent to exposure from hundreds of chest radiographs (17) (18) (19) (20) . Which is the most appropriate protocol for CTPA? During pregnancy there are some hemodynamically changes like increase in blood volume, cardiac output dhe cardiac frecuency. All of them produce an increase at about sixfold the "thoracoabdominal pump" in supine position and in full inspiration. This can create a" transient interruption of contrast", which suggest PE (false positive) ( figure 3) . It happens until 39 % of patients not following the right protocols. 
Methods of Reducing the Radiation Dose to the Maternal Breast and Fetus at CT Pulmonary Angiography 17
Thin-layer bismuth breast shield During the second and third trimesters of pregnancy, the gravid uterus increases in size and displaces the pelvic contents from their normal locations.
In the same way like in PE is difficult the definition of absolute indication for diagnostic imaging. Ultrasonography (US) is considered the imaging study of choice for evaluation of abdominal pain in pregnant patients, MR imaging is a valuable adjunct to US in evaluation of pregnant patients with acute right lower quadrant (RLQ) pain who have inconclusive US results. CT should not be used because the radiation damages the embryogenesis and can cause carcinogenesis. CT can be performed in the second and third trimesters if MR imaging is unavailable or if there is lack of expertise (figure 4). MR examination is thought to be safe in pregnancy and can be used regardless of the trimester when the outcome of the examination has the potential to affect the care of the patient. Examinations are performed at a field strength of 1.5 T with the patient in the supine position and with a body phased-array coil. Intravenous contrast agents are not used.
The MR imaging protocol for pregnant patients is detailed in table 5. Singleshot fast SE images are acquired in the three orthogonal planes (axial, coronal, and sagittal). Single-shot imaging provides a motion-insensitive strategy even in the presence of severe fetal motion. Axial single-shot fast SE images with frequency-selective fat saturation pulses improve the detection of inflammatory changes and edema. Axial TOF GRE T2*-weighted images are used to differentiate the normal appendix from the commonly seen dilated venous tributaries of the right gonadal Axial T1-weighted inphase and opposed-phase GRE images are valuable to identify hemorrhagic and fat-containing lesions. 
Urinary Tract Disorders
Nephro-and ureterolithiasis represent the most common causes of abdominal pain of urologic origin. US is frequently used as a screening examination, as US is a sensitive and specific test for diagnosing hydronephrosis and does not expose the patient or fetus to ionizing radiation. 22-24 However, the differential diagnosis of hydronephrosis in the pregnant patient is confounded by physiologic hydronephrosis of pregnancy, which is thought to be caused by compression of the ureters between the gravid uterus and the linea terminalis. 25 Physiologic hydronephrosis of pregnancy occurs in >80% of pregnant women, more commonly occurs on the right than the left, and is generally seen beginning in the second trimester. 25 Low-dose NCCT has been shown to be a sensitive and specific test for diagnosing stones in pregnant patients Visualization of stones in the urinary tract is challenging with MR imaging, particularly intrarenal stones and those at the ureterovesical junction. 
Iodinated contrast media in pregnancy
In general, intravascular contrast media should be avoided in pregnancy, in order to avoid any possible hazard to the fetus. In vitro experiments have shown iodinated contrast to be mutagenic to human cells. 26 Reassuringly, animal studies have failed to show an in vivo teratogenic effect. 27, 28 The iodine content of contrast media has the potential to produce neonatal hypothyroidism, and this has been observed after the direct instillation of ionic contrast into the amniotic cavity during amniofetography. 29 The intravascular use of non-ionic contrast media has been reported to have no effect on neonatal thyroid function. 30 It is standard pediatric practice to screen all neonates for hypothyroidism, but it is particularly important to perform this test in the infants of mothers who received iodinated contrast during pregnancy. 31
Gadolinium contrast in pregnant patients
The conclusion of a recent large cohort study from Ontario, Canada (Ray JG et al. JAMA. 2016;316(9):952-961) states, "Exposure to MRI during the first trimester of pregnancy compared with nonexposure was not associated with increased risk of harm to the fetus or in early childhood. Gadolinium MRI at any time during pregnancy was associated with an increased risk of a broad set of rheumatological, inflammatory, or infiltrative skin conditions and for stillbirth or neonatal death.
Intravenous gadolinium is teratogenic in animal studies. 32 While teratogenic effects have not been observed in a small number of human studies where gadolinium has been given in pregnancy, 33, 34 it is clear that gadolinium should not be administered in pregnancy unless there is an absolutely essential clinical indication, particularly during the period of organogenesis.
Administration of gadolinium later in pregnancy may be reasonable, although such indication would likely be for a maternal or obstetric indication rather than for evaluation of a fetal abnormality. Examples might include gadolinium enhanced imaging for a maternal brain tumor or suspected placenta accreta. Gadolinium crosses the placenta where it is presumably excreted by the fetal kidneys into the amniotic fluid. In the era of gadolinium-induced nephrogenic systemic fibrosis, this raises theoretical concerns of toxicity related to disassociation and persistence of free gadolinium. Such concerns reinforce the regulatory advice on gadolinium use in pregnancy. The 2007 ACR guidance document for safe MRI practices recommends that intravenous gadolinium should be avoided during pregnancy and should only be used if absolutely essential; furthermore, the risks and benefits of gadolinium use must be discussed with the pregnant patient and referring clinician. 35 Gadolinium is classified as a category C drug by the Food and Drug Administration and can be used if considered critical (only to be administered "if the potential benefit justifies the potential risk to the fetus").
The American College of Gynecology and Obstetrics recommends that pregnant patients should be reviewed on a case-to-case basis, and the riskbenefit ratio needs to be made by the physicians involved. There are no known biological effects of MRI on fetuses. Gadolinium should be avoided when examining a pregnant patient.
Conclusions
Modalities that do not use ionizing radiation, such as US and MR imaging, should be the preferred examinations for evaluating an acute condition in a pregnant patient. However, no examination should be withheld when an important clinical diagnosis is under consideration. Exposure to ionizing radiation may be unavoidable, but there is no evidence to suggest that the risk to the fetus after a single imaging study and an interventional procedure is significant. All efforts should be made to minimize the exposure, with consideration of the risk versus benefit for a given clinical scenario. 
